Chief Cushie ~MaryO~ Posted November 3, 2002 Chief Cushie Report Share Posted November 3, 2002 Trial Information Summary: Hypopituitary Control and Complications Study Dr. Stanley Korenman of UCLA's Division of Endocrinology is conducting a study to look at the effects of the long-term use of Growth Hormone Therapy (Humatrope, an FDA approved medication). The study involves measurements of blood levels of hormones, bone density and body fat every 6 months for 5 years (a total of 11 visits). Study Criteria: Be over 18 years of age Have known pituitary disease, either as a child or as a result of pituitary tumors Be taking hormone replacement Have health insurance Be interested in Growth Hormone Therapy Contact: Care Felix, Clinical Research Coordinator UCLA Medical Center Office of Clinical Trials 10900 Wilshire Blvd, Suite 170 Los Angeles, CA 90024 Telephone: 310-794-8900 Fax: 310-794-8902 Email: cfelix@mednet.ucla.edu Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.